An electric-field-responsive paramagnetic contrast agent enhances the visualization of epileptic foci in mouse models of drug-resistant epilepsy

Cong Wang,Wanbing Sun,Jun Zhang,Jianping Zhang,Qinghua Guo,Xingyu Zhou,Dandan Fan,Haoran Liu,Ming Qi,Xihui Gao,Haiyan Xu,Zhaobing Gao,Mei Tian,Hong Zhang,Jianhong Wang,Zixuan Wei,Nicholas J. Long,Ying Mao,Cong Li
DOI: https://doi.org/10.1038/s41551-020-00618-4
IF: 28.1
2020-09-28
Nature Biomedical Engineering
Abstract:For patients with drug-resistant focal epilepsy, excision of the epileptogenic zone is the most effective treatment approach. However, the surgery is less effective in the 15–30% of patients whose lesions are not distinct when visualized by magnetic resonance imaging (MRI). Here, we show that an intravenously administered MRI contrast agent consisting of a paramagnetic polymer coating encapsulating a superparamagnetic cluster of ultrasmall superparamagnetic iron oxide crosses the blood–brain barrier and improves lesion visualization with high sensitivity and target-to-background ratio. In kainic-acid-induced mouse models of drug-resistant focal epilepsy, electric-field changes in the brain associated with seizures trigger breakdown of the contrast agent, restoring the T1-weighted magnetic resonance signal, which otherwise remains quenched due to the distance-dependent magnetic resonance tuning effect between the cluster and the coating. The electric-field-responsive contrast agent may increase the probability of detecting seizure foci in patients and facilitate the study of brain diseases associated with epilepsy.
engineering, biomedical
What problem does this paper attempt to address?